Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it read-only, open-world, idempotent, and non-destructive. The description adds rich non-obvious behavior: parallel fan-out across multiple sources, soft-failure of the USPTO source, expected empty FDA sections for drug-only companies, sources_used/sources_failed semantics, and resolved:false behavior for private companies. This far exceeds what annotations alone convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but dense and front-loaded with the most important routing guidance ('ALWAYS PREFER...'). Every listed source and return field serves a purpose, and with no output schema present the detail is justified. It loses one point only because a shorter structured summary could make the many clauses easier to scan.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

This is a complex, multi-source tool with no output schema, yet the description inventories the return sections (cik, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/failed) and explains failure semantics for each. An agent has everything needed to invoke it correctly and interpret its output.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds value by explaining that 'type' accepts 'company' or 'ticker' interchangeably, that value can be a ticker, zero-padded CIK, or company name, and that name resolution happens via SEC EDGAR — plus the resolved_from/resolved_to nuance. This enriches the schema without contradicting it.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings ('Tell me about X', 'research Acme') and states a precise capability: a full cross-source profile of a US public company in one parallel call. It clearly distinguishes itself from single-pack lookups and other resolution-style tools by defining its holistic scope and return payload.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly instructs 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view', giving both a when and a when-not. It also states accepted input forms (ticker, CIK, or name), the private-company fallback behavior, and the 'person/place coming soon' boundary, so an agent knows exactly when to route to it.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tools have unclear boundaries: ask_pipeworx_beta currently behaves identically to ask_pipeworx, and the five Polymarket tools (arbitrage, edges, bet_research, fill_risk, edge_tracker) overlap heavily in the 'should I bet on X' use case. The detailed descriptions help, but an agent could easily misselect between these clusters.

Naming Consistency2/5

Naming is highly inconsistent: verb_noun (ask_pipeworx, compare_entities, resolve_entity), noun_noun (entity_profile, table_meta, polymarket_edges), single verbs (remember, forget, recall), and brand-prefixed compounds (pipeworx_trending, polymarket_kalshi_spread) are all mixed together. The server name 'Stat Gl' also doesn't align with the Pipeworx-heavy tool set.

Tool Count2/5

34 tools is well beyond the 25+ threshold that signals an oversized surface, and the set spans disparate domains: data querying, prediction markets, entity research, memory, subscriptions, and even niche utilities like generate_llms_txt and scan_dependency. While each tool has a described purpose, the count feels bloated for a coherent server.

Completeness4/5

Within its actual domains, coverage is strong: query, grounded verification, deep research, claim validation, entity profiles, comparisons, memory CRUD, and subscription lifecycle are all present, plus a complete Statistics Greenland browse/schema/query trio. Minor gaps exist (e.g., limited subscription event types, US-centric company profiles), but agents can typically find a working path without dead ends.